✦ LIBER ✦

Safety, tolerability, pharmacokinetics and pharmacodynamics of belimumab in Japanese patients with mild to moderate systemic lupus erythematosus

✍ Scribed by Yamada, Masanori; Akita, Mikio; Nakagawa, Tomofumi; Takahashi, Naoki; Endo, Akira; Yoshida, Pascal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety profile of belimumab pl

✍ Joan T. Merrill; Ellen M. Ginzler; Daniel J. Wallace; James D. McKay; Jeffrey R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Safety, tolerability and pharmacokinetic

✍ Arai, Heii; Umemura, Kazao; Ichimiya, Yosuke; Iseki, Eizo; Eto, Ko; Shibata, Nob 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Efficacy and safety of belimumab in pati

✍ Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Le 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 239 KB

Safety, tolerability, pharmacokinetics a

✍ Landen, Jaren; Andreasen, Niels; Cronenberger, Carol; Schwartz, Pam; Börjesson-H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety profile of belimumab: pooled data

✍ Wallace, D.; Navarra, S.; Petri, M.; Gallacher, A.; Thomas, M.; Furie, R.; Levy, 📂 Article 📅 2012 🏛 SAGE Publications 🌐 English ⚖ 138 KB

D1 Multiple dose safety, pharmacokinetic

✍ D.L. Neefe; K.J. Klamerus; M.M. Battle; P.R. Mayer 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB